Brinicombe commits to bolus market with Rumbol acquisition

Animal health and nutrition manufacturing group, Brinicombe, has acquired the original slow-release trace element bolus manufacturer, Rumbol Products Ltd, further cementing the business’ position in the bolus marketplace.

Keith Greig, managing director of Brinicombe and now also Rumbol; explains the two companies first set up a joint venture to manufacture and distribute EnduraBol cattle boluses in 2020.

“From the start it was clear that Rumbol was the best bolus manufacturer in the business, with its director, Dr. Stuart Ritchie continuing the legacy of his father Norman Ritchie, in advocating the firm’s strong values of quality and innovation – which resonate with our own,” he said.

To ensure a consistent service, supply and quality of our products, we aim for ‘ownership’, where at all possible, of our supply chains, so it made sense to acquire Rumbol when the opportunity arose.

Greig explained that while Brinicombe is now the parent company, Rumbol will operate as a standalone subsidiary to the group, with Brinicombe remaining a customer of the company.

“Nothing will change at a commercial level, meaning our customers will continue to receive the same top quality products, service and support.

“We’re pleased that while Dr. Ritchie has stepped away from directorship, he will still be involved in the business, in a part-time, consultancy capacity.”

Staff to remain in position

Like all the company’s staff, Rumbol’s general manager, Glen Dove, will remain in position and lead the day-to-day running of the operation, with the strategic support of Greig as joint managing director of Brinicombe and Rumbol.

“Having worked with the Brinicombe team for over 18 months, we’re delighted that a successful business that shares our values and culture will be taking ownership of Rumbol, offering both financial and marketplace stability,” said Dove.

He confirmed that production will continue at Rumbol’s current Clydebank factory, that holds Good Manufacturing Practices (GMP) certification.

“This allows us to manufacture licenced products to complement the existing FAMI-QS quality certification,” he added.